Silver Book Fact

Annual AFib-related stroke Medicare costs

Stroke in Medicare patients with atrial fibrillation who were not treated with anticoagulants, cost Medicare $4.8 billion each year in direct costs. Those who had strokes despite prophylactic treatment cost an additional $3.1 billion.

Caro, JJ. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation. Am J Managed Care. 2004; 10(14): S451-61. An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation

Reference

Title
An Economic Model of Stroke in Atrial Fibrillation: The cost of suboptimal oral anticoagulation
Publication
Am J Managed Care
Publication Date
2004
Authors
Caro, JJ
Volume & Issue
Volume 10, Issue 14
Pages
S451-61
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Atrial Fibrillation prevalence increase from 1992 to 2002
    Among Medicare patients ages 65 and older, atrial fibrillation prevalence increased from 3.2% in 1992 to 6.0% in 2002–with higher prevalence in older patients.  
  • Ischemic strokes caused by AFib
    Atrial fibrillation is responsible for at least 15% to 20% of all ischemic strokes.  
  • Projected AFib incidence, 2050
    If current incidence estimates are applied to Census Bureau projections, by 2050 the number of Americans with atrial fibrillation could exceed 12 million. If increases in incidence continue, that number could…  
  • Annual strokes from AFib
    Atrial fibrillation accounts for between 75,000 and 100,000 strokes per year.  
  • AFib, an economic burden
    AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study…